TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman June 29, 1979